<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Advancement

Alumni    Pharmacy    Advancement

Pharmacy Was a Family Affair

Perhaps Marguerite Cole Moore, ’60, was predestined to become a pharmacist. Her father, Wallace Cole, grew up in Salida, Colorado, and worked there for Wagoner’s Drug Store. When he graduated from high school in 1924, he worked in Denver for Maier Drug and Strickland Drug Company, prior to enrolling in the Capitol College of Pharmacy. After graduating in 1928, he purchased a drug store in Center, Colorado. Eventually, he ended up buying Pioneer Drug in Lamar, Colorado, which he renamed Cole’s Prescription Pharmacy. He received his fifty-year certificate of Pharmacy Registration in 1978.


Author SOP Communications | Publish Date January 14, 2022
Full Story

Alumni    Philanthropy    Pharmacy    Advancement    Health Sciences    Integrative Health    Medicine

CU Pharmacy Alumnus Built a Legacy in Alternative Medicine

Longtime friend and supporter, Henry Leopold Strauss, 93, passed away peacefully on April 8, 2021 at the home where he lived for the past 60 years. Strauss, RPh '51 leaves a lasting legacy with the University and Colorado and the Skaggs School of Pharmacy and Pharmaceutical Sciences, his alma mater.


Author SOP Communications | Publish Date April 30, 2021
Full Story

School of Pharmacy In the News

Medscape

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk

news outletMedscape
Publish DateFebruary 13, 2024

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, according to an editorial by Robert Page, PharmD

Full Story
KDVR

Colorado company developing potential prescription psilocybin product

news outletKDVR
Publish DateJanuary 17, 2024

Dr. David Kroll, PhD, says right now psilocybin is listed as a schedule one drug with no medical benefit and a high potential for abuse. “So, it is a risky proposition for these companies," he said, "but the clinical trials that have come out to date have been so promising that these companies have been able to acquire investors."

Full Story
The Denver Post

Littleton company developing psilocybin microdosing drug in hopes of FDA approval

news outletThe Denver Post
Publish DateJanuary 09, 2024

Though they hope to gain FDA approval soon, it may take some time. Dr. David Kroll, PhD, said the company will have additional hurdles to clear with the agency. 

Full Story
Neurology Today

Neurology Drugs Are Getting Better—and More Expensive—With More Prior Authorization Hassles

news outletNeurology Today
Publish DateJanuary 04, 2024

“The payers are trying to squeeze wherever they can,” said Dr. Kavita Nair, PhD, FAAN, a neurology professor and pharmacy outcomes researcher at the University of Colorado and vice chair of the American Academy of Neurology's Coding and Payment Policy Subcommittee.

Full Story